Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  bromodeoxyuridine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-21 of 21 for your search:
Start Over
Phase III Randomized Study of Radiotherapy with vs without BUDR and Followed by PCV (PCB/CCNU/VCR) for Anaplastic Astrocytomas
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9404, NCCTG-947251, SWOG-9340, RTOG-94-04
Phase III Randomized Comparison of Conventional Fractionated Radiotherapy with vs without BUdR in Patients with Tumors Metastatic to the Brain
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: NCOG-6G852, NCI-T86-0222D, T86-0222
Phase I/II Radiotherapy with BUdR Sensitization followed by Chemotherapy with PCV (PCB/CCNU/VCR) for Primary Malignant Brain Tumors
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: NCI-D82-004-688, BTRC-8222
Phase I/II Radiosensitization with Intra-Arterial BUDR plus Cranial Radiotherapy in Patients with Malignant Gliomas (Summary Last Modified 12/92)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MICH-T87-0015, NCI-T87-0015O, T87-0015
Phase II Study of Accelerated Concomitant Boost Radiotherapy in Transitional Cell Carcinoma of the Bladder (TCCB) (Summary Last Modified 08/1999)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MCC-RAD-9305, NCI-T96-0071, T96-0071
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
Phase: Phase II
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000066413, RUSH-AML-9754, ALZA-RUSH-AML-9754, NCI-V98-1445, NCT00003405
Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2012-02297, 98-374, CDR0000066989, UCHSC-98374, NCI-T98-0058, T98-0058, NCT00003832
Phase II External Beam Radiotherapy plus BUdR Followed by PCV (PCB/CCNU/VCR) for Primary Malignant Brain Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: NCOG-6G821, NCOG-6G-82-1
Phase I Study of Bromodeoxyuridine (NSC-38297) Given by Peripheral Venous Infusions
Phase: Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-80-C-143, NCI-T83-0981N
Phase I Pilot Study of Intra-Arterial Radiosensitization with BUdR plus Radiotherapy, Followed by Intra-Arterial BCNU in Treatment Failures, in Adult Patients with Malignant Gliomas
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MICH-125-36-2971, NCI-T83-1201H, T83-1201
Phase I Chemotherapy with BUDR Administered by Hepatic Arterial Infusion in Patients with Colorectal or Hepatobiliary Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 16
Sponsor: NCI
Protocol IDs: MICH-PCPP12-86, NCI-T86-0253O, T86-0253
Phase I Study of BUDR and Radiotherapy in Patients with Malignancies Involving the Liver and/or Bile Ducts (Summary Last Modified 07/97)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCUM-9141, NCI-T91-0275D, T91-0275
Phase I Study of BUDR or IUDR and Interstitial Radiotherapy in Patients with Recurrent Malignant Gliomas (Summary Last Modified 06/92)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BTRC-9101, NCI-T91-0228H, T91-0228
Phase I Pilot Study of Continuous-Infusion BUDR and Radiotherapy in Patients with Localized Pancreatic Cancer (Summary Last Modified 06/92)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCUM-9127, NCI-T92-0034D, T92-0034
Standard Radiotherapy and BUDR, BCNU or MeCCNU/DTIC Chemotherapy vs Higher Dose Radiotherapy for Malignant Gliomas
Phase: No phase specified
Type: Treatment
Status: Completed
Age: under 71
Sponsor: NCI
Protocol IDs: EST-1374, RTOG-7401
Start Over